Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of intravenous artesunate in severe malaria
ChiCTR-OPC-17013106Phase 4Completed
- Sponsor
- Guangxi Center for Disease Control and Prevention
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate in malaria (2 arms), sponsored by Guangxi Center for Disease Control and Prevention. Primary endpoints: Glasgow Coma Scale, Plasmodium blood smear and 1 more. Started Dec 2009; status: completed.
02
Drugs
artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on ChiCTR-OPC-17013106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17013106.